Literature DB >> 8957157

A practical guide to when (and how) to withdraw antiepileptic drugs in seizure-free patients.

D Schmidt1, L Gram.   

Abstract

Most patients with epilepsy will become seizure-free on antiepileptic drugs (AEDs) within a few years of diagnosis. More than 60% will remain so when the medication is withdrawn. After assessing the risks and benefits for the individual patient, withdrawal may be considered by the physician and informed patient or parent if the patient meets the following profile: normal neurological examination, normal IQ, normal electroencephalogram (EEG) prior to withdrawal, seizure-free for 2 to 5 years or longer, and no juvenile myoclonic epilepsy. AEDs can be safely withdrawn in the seizure-free patients over the course of 6 months, possibly even faster, especially in children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957157     DOI: 10.2165/00003495-199652060-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  10 in total

1.  Low morbidity and mortality of status epilepticus in children.

Authors:  J Maytal; S Shinnar; S L Moshé; L A Alvarez
Journal:  Pediatrics       Date:  1989-03       Impact factor: 7.124

2.  Randomised study of antiepileptic drug withdrawal in patients in remission. Medical Research Council Antiepileptic Drug Withdrawal Study Group.

Authors: 
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

3.  Discontinuing antiepileptic drugs in children with epilepsy: a prospective study.

Authors:  S Shinnar; A T Berg; S L Moshé; H Kang; C O'Dell; M Alemany; E S Goldensohn; W A Hauser
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

4.  Relapse following discontinuation of antiepileptic drugs: a meta-analysis.

Authors:  A T Berg; S Shinnar
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

5.  [Total or partial withdrawal of antiepileptic drugs].

Authors:  D Schmidt
Journal:  Rev Neurol (Paris)       Date:  1987       Impact factor: 2.607

6.  Discontinuing antiepileptic drugs in children with epilepsy. A comparison of a six-week and a nine-month taper period.

Authors:  M Tennison; R Greenwood; D Lewis; M Thorn
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

7.  Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group.

Authors:  A Jacoby; A Johnson; D Chadwick
Journal:  Epilepsia       Date:  1992 Nov-Dec       Impact factor: 5.864

8.  Remission of epilepsy: results from the National General Practice Study of Epilepsy.

Authors:  O C Cockerell; A L Johnson; J W Sander; Y M Hart; S D Shorvon
Journal:  Lancet       Date:  1995-07-15       Impact factor: 79.321

9.  Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.

Authors:  M de Silva; B MacArdle; M McGowan; E Hughes; J Stewart; B G Neville; A L Johnson; E H Reynolds
Journal:  Lancet       Date:  1996-03-16       Impact factor: 79.321

10.  Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study.

Authors:  A P Aldenkamp; W C Alpherts; G Blennow; D Elmqvist; J Heijbel; H L Nilsson; P Sandstedt; B Tonnby; L Wåhlander; E Wosse
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

  10 in total
  1 in total

Review 1.  Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.

Authors:  Timothy E Welty
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.